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Summary. Two transplantable, highly immunogenic syngeneic C57BL fibro-
sarcomas, FS1 and FS6, were shown to have tumour-specific rejection antigens,
as shown by excisionof the primary tumours and i.p. or i.m. injection of graded doses
of the specific and unrelated tumour cells. I.p. challenge with tumour cells induced
a large and relatively long-lasting increase in numbers of peritoneal leucocytes.
Macrophage monolayers prepared from such exudates were, in general, non-specifi-
cally cytotoxic, though occasional specific cytotoxicity was detected. T lymphocytes
isolated from exudates were shown to kill in a specific manner. When immunized
mice were challenged with the specific tumour cells to elicit large numbers of peri-
toneal cytotoxic cells, and with graded doses of the non-cross-reacting tumour cells
at the same time or at various times thereafter, growth of the non-related tumours
occurred in all cases and only the specific tumour was rejected. Moreover, Winn
tests, in which the inflammatory cells were mixed with unrelated tumour cells and
implanted i.m., did not delay tumour growth. The relevance of these findings to the
role of macrophages and lymphocytes in syngeneic tumour rejection is discussed.
DURING the last decade, strong evidence
has been presented that lymphocytes,
macrophages and more recently, natural
killer cells (NK cells) may be involved in
host anti-tumour defence mechanisms.
All 3 can be demonstrated to exert potent
in vitro cytotoxicity against neoplastic or
transformed cells, and this forms the basic
tenet for postulating that these cells may
be involved in surveillance. The major
difference between lymphocyte-mediated
cytotoxicity and macrophage-mediated
cytotoxicity is in their specificity ofaction.
Cytotoxic lymphocytes, elicited by expo-
sure of an animal to a particular antigen,
kill only tumour cells bearing the antigen
used for sensitization (Cerottini & Brunner,
1974); whereas cytotoxic macrophages,
however induced, generally damage any
tumour cells in vitro (Evans & Alexander,
1976). Thus, macrophage cytotoxicity is
often non-specific in that it extends to a
wide range of target cells, although it
can show some measure of selectivity in
that tumour cells are affected more than
are normal cells (Hibbs, 1974). Cytotoxic
macrophages can be elicited in the absence
of T lymphocytes in vitro (Alexander &
Evans, 1971) as well as in T-lymphocyte-
depleted mice (Kaplan et al., 1974;
Ghaffer et al., 1975; Pimm & Baldwin,
1975). These findings, together with the
abundant evidence that bacterial- and
parasite-injected animals (Hibbs, 1976)
from which cytotoxic macrophages can be
obtained, also show increased resistance to
tumour challenge, strongly support the
concept of macrophage involvement in
surveillance.
In the experiments described below,
both macrophage- and lymphocyte-medi-
ated cytotoxicity were assessed in vitro
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after immunizing mice against syngeneic
fibrosarcomas, and an attempt was made
to correlate in vitro findings with the
capacity of immunized mice to reject
syngeneic tumours. The results indicated
that, although potent non-specific cyto-
toxicity could be detected in vitro, only
specific in vivo rejection could be demon-
strated.
MATERIALS AND METHODS
Mice.-8-10 week-old C57BL mice were
used throughout.
Tumours.-Two benzpyrene-induced syn-
geneic fibrosarcomas, designated FS1 and
FS6, were transplanted i.m. by injection of
a cell suspension prepared by enzymic
dispersal ofthe solid tumours using a mixture
of trypsin, collagenase (0.05%) and DNase
in Medium 199. Cell cultures were prepared
by growing enzyme-dispersed neoplastic
cells in RPMI1640 supplemented with
25 mm Hepes and L-glutamine, 10% foetal
bovine serum and antibiotics (growth
medium). Cells were sub-cultured twice
weekly by rapidly detaching cells with warm
0 25% trypsin (Sigma 2X crystallized),
washing with TC 199 and resuspending them
in growth medium. The doubling time ofthese
2 types of fibrosarcoma cells in culture
was , 18--24 h, often with an initial lag
phase of up to 18 h.
Immunization.-Syngeneic mice immu-
nized against each tumour type by s.c.
injection of 106 cells followed by tumour
excision 10 days later. Both FS1 and FS6
fibrosarcomas were shown to be highly
immunogenic, as described in the text.
Macrophage monolayers.-Peritoneal exu-
date cells (PEC) were collected in TC 199
from normal (that is unstimulated) or
tumour-challenged immunized mice and
, 106 macrophages (with other cell types)
were seeded into 1-6 cm Linbro wells. Macro-
phages were tentatively identified on the
basis of morphology under phase-contrast
microscopy. After repeated washings by
rinsing with medium from a Pasteur pipette,
each monolayer consisted of 7 x 105-
106 macrophages (90-95% non-specific ester-
ase positive) with a low percentage ( < 5%)
of small round cells and polymorphs. For
convenience, these monolayers of adherent
cells are referred to as macrophage mono-
layers.
T Lymphocytes.-PEC were seeded into
75 ml culture flasks and incubated at
37°C for 1 h. Flasks were then gently agi-
tated and non-adherent cells were collected,
centrifuged, and resuspended in growth
medium. To assess T-lymphocyte content
cells were mixed at 4°C with 1 in 10 anti-0
serum (Thy 1.2) (C3H anti-AKR, Searle Ltd)
diluted in TC 199. In preliminary experiments
10-1M sodium azide was incorporated to
prevent capping when the antiserum was
added. In subsequent experiments this
proved unnecessary as long as the cells and
serum were kept at 4°C. After 30 min, cells
were washed and resuspended in 1 in 10
guinea-pig serum, absorbed with mouse
lymphoma cells (1:1 v/v) as a source of
complement. Lysis was assessed by phase-
contrast microscopy and by trypan-blue
exclusion.
Winn Assay.-PEC were collected from
tumour-immunized mice 5 days after i.p.
challenge with 106 specific tumour cells, and
from normal mice 3 days after i.p. injection
of 1 ml thioglycollate medium. PEC were
washed twice by centrifugation in siliconized
tubes and resuspended at 108 cells/ml. Equal
volumes of tumour cells and PEC were
mixed and 0-1 ml injected i.m. per mouse, so
that each mouse received 105 tumour cells and
5 X 106 PEC. When tumours became palp-
able, measurements of 2 leg diameters were
taken every 4 days.
Cytotoxicity.-This term as defined else-
where (Evans & Alexander, 1976) refers to the
extent of damage or disturbance of function
induced in a target cell after interaction
with an effector cell, and embraces both
growth inhibition and lysis as measures of
cytotoxicity.
Cytoxicity Assays.-Two assays were run
in parallel:
(a) Growth Inhibition. Macrophage mono-
layers were challenged with 5 x 104 FS1 or
FS6 cells in 1.5 ml of growth medium.
After 72 h at 37°C, 2 x 107 sheep red blood
cells (SRBC) coated with mouse-anti-SRBC
serum (EA) in 0-1 ml were added and incu-
bated for a further 30 min. The medium was
then gently removed and replaced with 1 ml
of 0.1% trypsin, which after 20 min at 37°C
detached adherent tumour cells which were
then counted in a haemocytometer. Any
macrophages present could be readily dis-
tinguished by the presence of phagocytosed
EA. Growth inhibition was calculated from
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the formula:
No. oftumour cells on_No. oftumourcells on
normalmacrophages immune macrophages
No. of tumour cells on normal macrophages
x 100
(b) Lysis. Subconfluent monolayers of
FS1 or FS6 cells were incubated with
5 - (1251)-iodo-2'-deoxyuridine(125IUdR-sp.
act. 5 Ci/mg) at 0.1 ,uCi/ml growth medium
for 4 h, rinsed with TC 199 and resuspended
by incubation for up to 5 min in 0-25%
trypsin. After gentle centrifugation cells
were resuspended in growth medium. One
ml containing 5 X 104 125IUdR-labelled cells
was added to each Linbro well and incubated
for 48-72 h. For lymphocyte-mediated lysis
106 lymphocytes were mixed with the same
standard number of target cells in Linbro
wells for 48 h. The culture medium from each
well was then recovered and centrifuged to
deposit any cells carried over. Residual cells
in the wells were lysed with 1% sodium
dodecylsulphate. The lytic index was calcu-
lated from the formula:
%1251 release from tumour cells on immune
macrophages - %1251 release from tumour
cells on normal macrophages where %1251
release
1251 in supernatant x 100 1251 in supernatant + 1251 in lysate
At least 3 wells were used for each sample.
In experiments carried out over a period of
one year, the release of 1251 from FS1 and
FS6 cells cultured alone or in the presence
of normal macrophages for 72 h ranged from
14-35%.
RESULTS
Specificity of rejection by tumour-immun-
ized mice
This was demonstrated by challenging
C57BL mice, immunized with FS1 or FS6
cells, with graded doses ofeach ofthe two
fibrosarcomas i.p., and recording the
survivaltimes. TableI shows thatrejection
after immunization and challenge was
completely specific. Experiments involv-
ing i.m. challenge confirmed this specificity
(data not given).
Inflammatory response after i.p. challenge
of immunized mice in relation to cell-
mediated cytotoxicity
(a) Macrophage mediated cytotoxicity.-
Mice immunized against FSI or FS6
fibrosarcomas were injected i.p. 10 days
after tumour excision with 106 specific
fibrosarcomacellsderivedfromenzymically
dispersed solid tumours. At dailyintervals,
4 ml of TC 199 were injected into groups
of 3-5 mice, and total cell yields per
mouse were estimated. Table II shows the
inflammatory response over a period of
7 days, together with the percentage of
macrophages in the exudate. Standard
deviations, which were calculated, are
omitted for clarity. It is also seen that
inflammation was induced in the immnu-
nizedmicewhetherthestimuluswas tumour
cells or culture medium. Control mice did
TABLE I.-Immunogenicity ofFS1 and FS86fibrosarcomas in C57BL mice
Challenged
Mice with
Control, unimmunized FS6 cells
Immunized with
FS6 cells
Immunized with
FSI cells
Control, unimmunized FSI cells
Immunized with
FS6 cells
Immunized with
FSI cells
Number ofsurvivors*/Number ofmice
103
5/5
104
1/5
105
0/5
5/5 5/5 5/5
106
0/5
107 cells
0/5
5/5 4/5
5/5 1/5 0/5 0/5 0/5
4/5 2/5 0/5 0/5 0/5
3/5 1/5 0/5 0/5 0/5
5/5 5/5 5/5 5/5 1/5
* Mice still free of tumour 90 days after challenge.
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TABLE II.--Total peritoneal cell content after i.p. challenge of immu,nized mice
with 106fibrosarcoma cells
Mice Immunized with
FS6 cells
FS6 cells
FS1 cells
FS1 cells
FS6 cells
FS6 cells
Normal C57BL mice
Normal C57BL mice
Challenged with
FS6 cells
FS1 cells
FSl cells
FS6 cells
Normal spleen cells
FS6 cells
Total cell numbers per mouse (X 106) on Day:
3 5 7
15-6 (31)*
14-0 (34)
12-1 (36)
9-1 (41)
12-8 (38)
8 - 1 (32)
7-5 (29)
23 - 1 (43)
12-5 (38)
25 1 (41)
16-2 (37)
17-0 (44)
24-5 (32)
16-4 (40)
20 - 1 (40)
16-3 (37)
9 2 (41)
9.7 (52)
* % of peritoneal macrophages per exudate.
not respond to these stumuli. Over a
period of 21 days after i.p. challenge, it
was seen that the total number of cells
peaked around Days 5 to 7, but was still
somewhat elevated on Day 21.
Fig. 1 (a and b) summarizes represen-
tative experimental data on macrophage-
mediated cytotoxicity for selected times
over a 12-day period. Fig l(a) shows
growth inhibition and lysis induced by
macrophage monolayers prepared from
exudates from mice immunized and chal-
lenged with FS6 cells. It is seen that
cytotoxicity was mainly non-specific. Both
FS6 and FS1 cells were inhibited in their
growth or were lysed, although not
infrequently it was more potent towards
the specific target cells. By Day 7 after
challenge of mice the cytotoxicity dis-
played by the adherent exudate cells was
occasionally specific. At this time strong
growth inhibition and lysis was exerted
against FS6 cells, whereas against FS1
cells there was only weak growth inhi-
bition.
Fig l(b) shows the cytotoxicity of
macrophages from mice immunized and
challenged with FSI cells. A similar type
of reaction was found, except that macro-
phage monolayers were almost invariably
non-specifically cytotoxic. Peritoneal
macrophages from unchallenged, immu-
nized mice, or from immunized mice
challenged with the non-cross-reacting
tumours, or thioglycollate medium, were
neither growth inhibitory nor lytic. Both
anti-FSI and anti-FS6 macrophages were
also cytotoxic towards two other sygeneic
fibrosarcoma cell lines, 2 allogeneic
fibrosarcoma cell lines and one allogeneic
lymphoma cell line (data not given).
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FIG. 1(a). Growth inhibition and lysis ofFS6
cells (0 0) and FS1 cells (0 O)
by peritoneal macrophages from mice
immunized against and challenged i.p. with
106 FS6 cells.
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TABLE III.-Cytotoxicity ofperitoneal lymphocytes from immunized mice*
Lymphocytes from
Mice immunized with FS6 cells
Mice immunized with FS1 cells
Lytic Index
Anti-O+C' v FS6 cells v FSL cells
25±5 0
+ 0 0
+
0 21±3
0 3±2
* Peritoneal lymphocytes harvested 6 days after specific i.p. challenge of
immunized mice, were incubated for 48 h with 125IUdR-labelled tumour cells at
an effector:target cell ratio of 20: 1.
TABLE IV.-Specificity of tumour-cell rejection by immunized mice
after 2 i.p. challenges
Challenged Rechallenged
i.p. with i.p. with*
106 FS1
106 FS6 106 FS6
106 FS6 106 FS1
106 FS6 104 FS1
- 106 FS6
104 FS6
106 FS1 106 FS1
106 FSI 106 FS6
106 FSI 104 FS6
No. survivorst/
No. mice challenged
0/5
5/5
0/5
0/5
0/5
0/5
5/5
0/5
0/5
Minimum survival
time (days)T
16
> 100
13
27
22
36
>100
19
40
* There was a 4-day interval between the 1st and 2nd i.p. challenge.
t Mice still free of tumour 90 days after challenge.
$ Time taken for the first mouse in each group to die, after which mice that developed
obvious i.p. tumours were killed to minimize trauma.
(b) Lymphocyte-mediated cytotoxicity.-
Non-adherent peritoneal cells from im-
munized or normal mice were tested for
their ability to lyse 1241-labelled tumour
cells in a 48 h assay at an effector:
target cell ratio of 201. Table III shows
that in all cases lysis was specific for the
immunizing antigen. The reaction was
T-lymphocyte mediated, as shown by
loss oflytic potential after pretreatment of
cells with anti-0 serum and complement.
Specificity of in vivo rejection after specific
i.p. stimulation
To ascertain whether non-specific in
vitro cytotoxicity was a reflection of non-
specific in vivo rejection, immunized mice
were challenged i.p. with 106 cells from the
appropriate fibrosarcoma, to induce the
appearance of cytotoxic macrophages,
and then challenged i.p. with 104, 105 or
106 cells from the non-cross-reacting
fibrosarcoma at the same time or 1-5 days
later. Because the results were similar
40
throughout, only the data from Day 5 are
summarized in Table IV. The minimal
survival times rather than median survi-
val times are given, because as soon as the
mice in any one group began to die the
remaining mice were killed to minimize
trauma caused by the enlarging tumour
masses and haemorrhage. The results
indicated that rejection was specific in all
instances. Even when threshold doses of
104 unrelated cells were given, there was
no difference in the survival rate compared
with that of control mice.
Adoptive transfer of immunity with
peritoneal-exudate cells from tumour im-
munized mice
Because of the problems associated
with visualisation of the emergence and
growth of i.p. tumours, Winn tests were
carried out. Exudates from immunized
mice challenged 5 days previously with
the appropriate tumour cells (106 cells)
Type of
C57BL mouse
Normal
Anti-FS6
Anti-FS6
Anti-FS6
Normal
Normal
Anti-FS1
Anti-FS1
Anti-FS1
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FIG. 1(b).-Growth inhibition andlysis of FS1
cells (0 0) and FS6 cells (0 O)
by peritoneal macrophages from mice
immunized against and challenged i.p.
with 106 FS1 cells.
or from normal mice injected with thio-
glycollate medium, were mixed with 105
tumour cells, at a ratio of 50 peritoneal
cells to 1 tumour cell, and injected i.m.,
as described in Materials and Methods.
Growth was assessed by measuring tumour
diameter. Fig. 2 (a and b) shows that
immune PEC conferred protection on
normal mice towards the specific im-
munizing tumour cells but there was no
significant decrease in either the rate of
emergence of unrelated tumours or in
their rate of progression.
DISCUSSION
The purpose of the above study was
two-fold: firstly, to find the best method
for elicitation of cytotoxic cells in tumour-
immunized mice; and secondly, to attempt
to correlate in vitro anti-tumour activity
with specific rejection seen in the im-
munized mice (See Table I). It was found
that elicitation of cytotoxicity was
tumour-specific, in that injection of the
unrelated tumour cells did not result in
the appearance of cytotoxic macrophages
orlymphocytes, eventhoughinflammation
was induced. Apart from demonstrating
that the specific antigen was required to
elicit cytotoxic cells, the experiments
showed that the non-specific induction of
an inflammatory response did not draw
cytotoxic cells into the peritoneal cavity,
i.e. induction of cytotoxicity was a
localized event. Two cytotoxic cell types,
macrophages and T lymphocytes, were
identified. Both are regarded as essential
components in both syngeneic tumour
rejection and allograft rejection (Cerotinni
and Brunner, 1974) whether alone or in
combination with humoral factors, the
macrophages perhaps amplifying T-cell
cytotoxicity (Lohmann-Mathes, 1976).
However, in vitro data indicated that
while T-cell killing was always immuno-
logically specific, macrophage cyto-
toxicity was in general non-specific.
Specifically cytotoxic T cells have also
been demonstrated in the peritoneal
cavity during BCG-induced rejection of
FS6 or FS1 (Parr et al., 1977). Asindicated
previously (Evans & Alexander, 1972a)
macrophages recovered from the peri-
toneal cavity of lymphoma-immunized
syngeneic mice soon after i.p. challenge
were non-specifically cytotoxic, but this
disappeared in time and, thereafter,macro-
phage cytoxicity was specific for the
tumour cells used for immunization. In
the case of the FS6 and FS1 fibrosar-
comas, the kinetics of production of
cytotoxic macrophages were somewhat
different from the lymphoma situation, in
that only occasionally were specifically
cytotoxic macrophages seen, and in
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general cytotoxicmacrophages
detected beyond Day 9, com
21-28 days in the case of
immunized mice (Evans &
1972b). The reason for this
probably lies in the nature of
cells. The recognition mechanis
in this form of non-specific ir
mediated cytotoxicity is ni
Although immunogenicity stuc
fibrosarcomas showed that in vi
was wholly specific (Table I) it
that cytotoxic macrophages we
ing some kind of shared cr
tumour-associated antigens in
been shown in certain oth
systems (Baldwin & Embete
Fritze et al., 1975).
uespite the tact that the permtoneal
cavity was apparently full of non-specific-
ally cytotoxic macrophages for several
days after specific i.p. challenge oftumour-
immunized mice, we found no evidence
for an innocent-bystander effect in vivo,
in that antigenically distinct tumour
cells, even in very low numbers, were not
rejected at these times (Table IV). Nor
was there any significant growth inhibi-
tion of unrelated tumour cells when
immune peritoneal macrophages were
I . . -V . " . , . "' 'I used in Winn tests (Fig. 2). These results
agree with other reports which also
showed no evidence for such an effect
(Klein & Klein, 1954; Zbar et al., 1970).
The latter report demonstrated that a
guinea-pig hepatoma (Line 7) induced
specific immunity after its excision, and
failed to protect against an unrelated
tumour, the Line 1 hepatoma. Our
findings would, however, appear to differ
from the several reports, summarized in
an excellent review by Hibbs (1976), in
nity with which there is good reason to suppose
(a) Mice that under conditions of adjuvant, bac-
Is + thio- terial or parasitic stimulation, non-specific anti-FS6 ) O). macrophage cytotoxicity may be relevant
FS1 cells to anti-tumour resistance in vivo. It is
ti-FS6 possible that, under these circumstances,
macrophage cytotoxicity is maintained
for a much longer time in vivo, and is
therefore more effective in controlling
couldnotbe tumour growth. Other possible reasons
pared with for the failure to demonstrate non-
lymphoma- specific resistance in our system are (1)
Alexander, that the cytotoxicity was blocked or
discrepancy inhibited in some way and was unable to
the tumour express itself in vivo, and (2) that perhaps
in involved the in vitro cytotoxic effects were exag-
iacrophage- gerated because of the prevalent cultural
ot known. conditions. This second possibility, if not
lies of these correct, is intrinsically of interest in
ivo rejection that it raises an issue, muted previously,
t is possible concerningtherelationshipbetweengrowth
re recognis- inhibition and lysis: whether they are
oss-reacting reactions with similar or different path-
vitro, as has ways (Evans & Alexander, 1976). Macro-
ier tumour phage cytotoxicity was assessed by growth
-ton, 1974; inhibition and lytic assays, because of the
overall evidence that macrophages may
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express a spectrum of cytotoxic reactivity
from transient growth inhibition to ir-
reversible lysis. In the event, this approach
was justified because, when lysis was
detectable, growth inhibition was un-
failingly very strong, but the reverse was
not necessarily true. The crux of the
problem seems to lie in the importance of
macrophage-mediated growth inhibition,
whether under some conditions it leads to
lysis directly, or whether its purpose is to
predispose the cells to attack by some
other effector mechanism, such as lysis by
T lymphocytes.
The conclusion reached from these
results is that specific rejection of FS1
and FS6 fibrosarcomas was mediated by
T lymphocytes, and possibly assisted by
macrophages. We found no evidence that
non-specific macrophage cytotoxicity was
operational in vivo, as measured by failure
of immunized mice to reject the unrelated
tumour cells, even though in vitro macro-
phages were potently cytotoxic. The
suggestion is that, while non-specific
macrophage cytotoxicity may play a role
in surveillance byinhibiting the emergence
of neoplasms, it may fail to exert an
effect against tumour cells which are
already relatively fast dividing.
These investigations were supported by a project
grant from the Medical Research Council.
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